Crystalline form of N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenyl- 1H-pyrazol-1-yl] pyrimidin-2-yl]amino]-4-methoxy-2-(morpholin-4-yl)phenyl]acrylamide, mesylate

Inventor(s)

• MSN Laboratories Private Limited, R&D Center, Hyderabad, India, Srinivasan Thirumalai Rajan, Sagyam Rajeshwar Reddy, Kommera Rajashekar, Kondeti Raju, Rajavel Bala murugan.Follow

Abstract

The present disclosure provides process for the preparation of N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2-(morpholin-4-yl)phenyl]acrylamide, mesylate salt represented by the following structural formula-1.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

Recommended Citation

MSN Laboratories Private Limited, R&D Center, Hyderabad, India, Srinivasan Thirumalai Rajan, Sagyam Rajeshwar Reddy, Kommera Rajashekar, Kondeti Raju, Rajavel Bala murugan., "Crystalline form of N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenyl- 1H-pyrazol-1-yl] pyrimidin-2-yl]amino]-4-methoxy-2-(morpholin-4-yl)phenyl]acrylamide, mesylate", Technical Disclosure Commons, ()
https://www.tdcommons.org/dpubs_series/12995